UniProtKB/Swiss-Prot P16671: Variant p.Val154Phe

Platelet glycoprotein 4
Gene: CD36
Feedback?

Variant information Variant position:

154 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Valine (V) to Phenylalanine (F) at position 154 (V154F, p.Val154Phe). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (V) to large size and aromatic (F) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Polymorphism:

Genetic variations in CD36 are involved in susceptibility to malaria and influence the severity and outcome of malaria infection [MIM:611162]. Additional information on the polymorphism described.
Other resources:

Links to websites of interest for the variant.

Variant rs5957 [ dbSNP | Ensembl ]

Sequence information Variant position:

154 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

472 The length of the canonical sequence.
Location on the sequence:

NFTVLNLAVAAASHIYQNQF V QMILNSLINKSKSSMFQVRT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         NFTVLNLAVAAASHIYQNQFVQMILNSLINKSKSSMFQVRT

Mouse                         NFTVLNLAVAAAPHIYQNSFVQVVLNSLIKKSKSSMFQTRS

Rat                           NFTVLNLAVAAAPHIYTNSFVQGVLNSLIKKSKSSMFQTRS

Bovine                        TFTILNLAVAAAPQLYPNTFMQGILNSFIKKSKSSMFQNRT

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	2 – 472	Platelet glycoprotein 4
Topological domain	30 – 439	Extracellular
Glycosylation	134 – 134	N-linked (GlcNAc...) asparagine
Glycosylation	163 – 163	N-linked (GlcNAc...) asparagine
Alternative sequence	144 – 203	Missing. In isoform 4.
Helix	152 – 164

Literature citations
Characterization of single-nucleotide polymorphisms in coding regions of human genes.
Cargill M.; Altshuler D.; Ireland J.; Sklar P.; Ardlie K.; Patil N.; Shaw N.; Lane C.R.; Lim E.P.; Kalyanaraman N.; Nemesh J.; Ziaugra L.; Friedland L.; Rolfe A.; Warrington J.; Lipshutz R.; Daley G.Q.; Lander E.S.;
Nat. Genet. 22:231-238(1999)
Cited for: VARIANT PHE-154;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.